Merck (MRK) Misses Q4 EPS by 6c, FY Guidance Tops Views

February 4, 2021 6:47 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Merck (NYSE: MRK) reported Q4 EPS of $1.32, $0.06 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.68 billion.


Merck sees FY2021 EPS of $6.48-$6.68, versus the consensus of $6.41. Merck sees FY2021 revenue of $51.8-53.8 billion, versus the consensus of $51.77 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities